targeting egfr induced oxidative stress by parp1 inhibition in glioblastoma therapy针对parp1抑制表皮生长因子受体诱导氧化应激的胶质母细胞瘤的治疗.pdfVIP

下载本文档

4
0
约 9页
2017-09-12 发布于上海
举报
版权申诉

targeting egfr induced oxidative stress by parp1 inhibition in glioblastoma therapy针对parp1抑制表皮生长因子受体诱导氧化应激的胶质母细胞瘤的治疗.pdf

1、本文档共9页，可阅读全部内容。
2、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。
3、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
4、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
5、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
6、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
7、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
8、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

targeting egfr induced oxidative stress by parp1 inhibition in glioblastoma therapy针对parp1抑制表皮生长因子受体诱导氧化应激的胶质母细胞瘤的治疗

Targeting EGFR Induced Oxidative Stress by PARP1 Inhibition in Glioblastoma Therapy 1. 1,2. 3 4 1 1 Masayuki Nitta , David Kozono , Richard Kennedy , Jayne Stommel , Kimberly Ng , Pascal O. Zinn , 1 5 6 7 4 Deepa Kushwaha , Santosh Kesari , Frank Furnari , Katherine A. Hoadley , Lynda Chin , Ronald A. 4 6 1 1,8 DePinho , Webster K. Cavenee , Alan D’Andrea , Clark C. Chen * 1 Department of Radiation Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, 2 Harvard Radiation Oncology Program, Boston, Massachusetts, United States of America, 3 Almac Diagnostics, Craigavon, Northern Ireland, United Kingdom, 4 Department of Medical Oncology, Belfer Institute for Applied Cancer Science, Dana-Farber Cancer Institute, Boston, Massachusetts, United States of America, 5 Department of Neurology, Moores UCSD Cancer Center, University of California San Diego, La Jolla, California, United States of America, 6 San Diego Branch, Ludwig Institute for Cancer Research, La Jolla, California, United States of America, 7 Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States of America, 8 Division of Neurosurgery, Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States of America Abstract Despite the critical role of Epidermal Growth Factor Receptor (EGFR) in glioblastoma pathogenesis [1,2], EGFR targeted therapies have achieved limited clinical eff